29 March 2022
Polaris raises €5 million to support its strong growth
Polaris, a pioneer in Omega 3 and leader in fatty acids with high concentrations of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), which play a key role in...
Life Sciences
28 March 2022
MaaT Pharma Announces First Patient Dosed in Phase 3 ‘ARES’ Trial Evaluating MaaT013 in Patients with Acute Graft-vs-Host-Disease
A French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for patients with cancer,...
11 March 2022
Microbiome Space in Spotlight as Microbiotica Sets Funding Record
Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and...
11 March 2022
Backing the Microbiome: The Investor Perspective
Life science research changes frequently, with new discoveries being published every day. Some of these discoveries form the basis of new biotech companies, but whether or not...
7 March 2022
Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics
Microbiotica, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, today announced the completion of a £50 million ($67 million) Series...
22 February 2022
Polaris and Golden Omega partner for the North American market
Polaris and Golden Omega are pleased to announce a new alliance which will allow Polaris to use Golden Omega’s extensive network in the North American Market for the...
20 February 2022
OIA launches project to produce alternative protein from dates
Focusing on its role in attracting foreign investments and advanced technologies to the sultanate, Oman Investment Authority (OIA) has signed an agreement with US-based...
14 February 2022
Maat Pharma and Skyepharma have entered a partnership to establish the first exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France
MaaT Pharma (EURONEXT: MAAT), a French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival...
19 January 2022
The start-up La Vie™ raises €25M and sets out to conquer the world with its new generation of plant-based meat
The first record raising of €25M in Series A financing from investment funds led by Seventure, and international celebrities that are committed to protecting the planet. This...
13 January 2022
Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge
DERMALA, a consumer dermatology company that develops novel treatments for chronic skin conditions, announces the brand's Grand Prize recognition in the global pitch...